
Syneos Health SYNH
Quarterly report 2023-Q1
added 05-10-2023
Syneos Health Depreciation & Amortization 2011-2026 | SYNH
Annual Depreciation & Amortization Syneos Health
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 236 M | 222 M | 242 M | 274 M | 180 M | 59.2 M | 56 M | 54.5 M | 58.5 M | 78.8 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 274 M | 54.5 M | 146 M |
Quarterly Depreciation & Amortization Syneos Health
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 61.6 M | - | - | - | 62.2 M | - | 17.7 M | 18.2 M | 57.9 M | - | 168 M | 112 M | 56.1 M | - | 182 M | 122 M | 61.2 M | - | 204 M | 136 M | 68 M | - | 96.6 M | 31.2 M | 15.6 M | - | 43.6 M | 14.5 M | 14.4 M | - | 13.8 M | 13.9 M | 14.2 M | - | 14.3 M | 11.3 M | 14.4 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 204 M | 11.3 M | 62.4 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M | ||
|
Bioventus
BVS
|
47 M | $ 8.99 | 1.35 % | $ 599 M | ||
|
Castle Biosciences
CSTL
|
16 M | $ 25.9 | 0.27 % | $ 719 M | ||
|
Aspira Women's Health
AWH
|
264 K | - | -6.19 % | $ 10.5 M | ||
|
DexCom
DXCM
|
252 M | $ 67.32 | 1.48 % | $ 26.3 B | ||
|
Guardant Health
GH
|
39.7 M | $ 88.75 | 1.8 % | $ 11.1 B | ||
|
Charles River Laboratories International
CRL
|
403 M | $ 153.71 | 1.14 % | $ 7.62 B | ||
|
CareDx, Inc
CDNA
|
15 M | $ 17.6 | 1.62 % | $ 938 M | ||
|
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | ||
|
Exact Sciences Corporation
EXAS
|
125 M | $ 103.94 | 0.09 % | $ 19.6 B | ||
|
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | ||
|
Fulgent Genetics
FLGT
|
24.9 M | $ 15.43 | 3.21 % | $ 467 M | ||
|
Biodesix
BDSX
|
5.77 M | $ 16.59 | -4.05 % | $ 2.15 B | ||
|
ICON Public Limited Company
ICLR
|
488 M | $ 100.49 | 2.95 % | $ 8.29 B | ||
|
Anixa Biosciences
ANIX
|
38.3 K | $ 2.89 | 1.76 % | $ 93.8 K | ||
|
IQVIA Holdings
IQV
|
1.14 B | $ 168.43 | 2.15 % | $ 29 B | ||
|
Danaher Corporation
DHR
|
750 M | $ 195.21 | 2.0 % | $ 139 B | ||
|
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | ||
|
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | ||
|
Pacific Biosciences of California
PACB
|
13 M | $ 1.38 | 1.47 % | $ 414 M | ||
|
Illumina
ILMN
|
354 M | $ 120.84 | 1.31 % | $ 19.2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
570 M | $ 198.61 | -0.17 % | $ 22 B | ||
|
QIAGEN N.V.
QGEN
|
203 M | - | - | $ 10.6 B | ||
|
Agilent Technologies
A
|
321 M | $ 112.75 | 0.82 % | $ 34.3 B | ||
|
BioNano Genomics
BNGO
|
14 M | $ 1.13 | 1.8 % | $ 1.44 M | ||
|
DarioHealth Corp.
DRIO
|
473 K | $ 8.75 | 3.92 % | $ 248 M | ||
|
NeoGenomics
NEO
|
36.1 M | $ 8.27 | 0.36 % | $ 1.06 B | ||
|
Neogen Corporation
NEOG
|
119 M | $ 9.27 | 1.76 % | $ 2.01 B | ||
|
Lantheus Holdings
LNTH
|
70.1 M | $ 80.45 | 2.48 % | $ 5.43 B | ||
|
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
1.23 M | $ 4.4 | 101.83 % | $ 129 M | ||
|
Medpace Holdings
MEDP
|
27.2 M | $ 455.15 | 0.33 % | $ 13.1 B | ||
|
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | ||
|
Mettler-Toledo International
MTD
|
51.1 M | $ 1 206.72 | 0.63 % | $ 24.9 B | ||
|
Celcuity
CELC
|
130 K | $ 114.11 | -0.69 % | $ 4.5 B | ||
|
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
7.62 M | $ 17.73 | 1.9 % | $ 397 M | ||
|
Twist Bioscience Corporation
TWST
|
24.9 M | $ 47.28 | 5.04 % | $ 2.83 B | ||
|
Invitae Corporation
NVTA
|
142 M | - | - | $ 21.2 M | ||
|
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | ||
|
Natera
NTRA
|
16.7 M | $ 198.38 | 0.35 % | $ 19.5 B |